The AVADI-1 study, sponsored by Jesús Moreno Fernández and conducted at Ciudad Real General University Hospital, evaluated adherence to vaccination guidelines for Influenza, Pneumococcal, and Hepatitis B in adult patients with Type 1 Diabetes Mellitus. With a cohort of 300 participants, the study highlights the importance of vaccination in this high-risk population, potentially influencing public health policies and vaccination strategies. The findings may provide insights for pharmaceutical companies involved in vaccine development and distribution, particularly in targeting diabetes patients. The study's completion and data availability could enhance market positioning for companies focusing on diabetes care and preventive measures.